Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Potassium channel tetramerization domain containing 9 pseudogene 5 (KCTD9P5) is classified as a processed pseudogene in the human genome and does not encode a functional protein. It shares sequence similarity with KCTD9, a gene encoding a member of the potassium channel tetramerization domain-containing protein family. As a pseudogene, KCTD9P5 is not known to function as an ion channel, receptor, or other canonical drug target. Some pseudogenes can have biological activity as non-coding RNAs affecting the expression of related genes, but there are no data indicating such a function for KCTD9P5 specifically. KCTD9P5 is a pseudogene, not a functional protein-coding gene. It is not considered a therapeutic target (receptor, enzyme, transporter, etc.) since it does not produce a functional molecule. No known disease associations, biomarkers, drug interactions, or mechanisms of action. No aliases were found in the main databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium channel tetramerization domain containing 9 pseudogene 5 (KCTD9P5).